Published in J Med Chem on February 01, 1985
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer. Br J Cancer (1992) 0.99
High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain. Drug Metab Dispos (2007) 0.89
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients. Br J Cancer (1991) 0.80
Treatment of breast cancer with aromatase inhibitors--current status and future prospects. Br J Cancer (1989) 0.75
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts. Br J Clin Pharmacol (1988) 0.75
Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer. J Med Chem (1995) 3.72
Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. Br J Cancer (2004) 3.32
Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase). J Steroid Biochem Mol Biol (1994) 3.19
Myelinated retinal nerve fibers. Am J Ophthalmol (1981) 2.45
The synthesis of oligoribonucleotides. IV. Preparation of dinucleoside phosphates from 2',5'-protected ribonucleoside derivatives. Tetrahedron (1968) 2.31
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitors. J Steroid Biochem Mol Biol (1997) 1.94
Long-term changes in arch form after orthodontic treatment and retention. Am J Orthod Dentofacial Orthop (1995) 1.77
Isolation and identification of products from alkylation of nucleic acids: ethyl- and isopropyl-purines. Biochem J (1975) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Reaction products from N-methyl-N-nitrosourea and deoxyribonucleic acid containing thymidine residues. Synthesis and identification of a new methylation product, O4-methylthymidine. Biochem J (1973) 1.50
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. Lancet (1994) 1.49
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
The beta 1----2-D-xylose and alpha 1----3-L-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin. Isolation, characterisation and comparison with other legume lectins. Eur J Biochem (1987) 1.45
The alkylation of 2'-deoxyguanosine and of thymidine with diazoalkanes. Some observations on o-alkylation. Biochem J (1973) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
The synthesis of oligoribonucleotides. II. Methoxymethylidene derivatives of ribonucleosides and 5'-ribonucleotides. Tetrahedron (1967) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. Lancet (1980) 1.38
The beagle: an appropriate experimental animal for extrapolating the organ distribution pattern of Th in humans. Health Phys (1988) 1.38
Chemical trapping of a reactive metabolite. The metabolism of the AZO-mustard 2'-carboxy-4-di-(2-chloroethyl)amino-2-methylazobenzene. Biochem Pharmacol (1972) 1.38
Occurrence of mammary tumors in beagles given radium-226. Radiat Res (1994) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol (1974) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene (2007) 1.27
Alkylation by propylene oxide of deoxyribonucleic acid, adenine, guanosine and deoxyguanylic acid. Biochem J (1972) 1.23
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis. J Med Chem (1995) 1.15
The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity. Biochem J (1972) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol (1979) 1.13
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol (1998) 1.10
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer. J Med Chem (1996) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
A new method for improving metaphase chromosome spreading. Cytometry A (2003) 1.03
Observation of anomalous upsilon(1S)pi+pi(-) and upsilon(2S)pi+pi(-) production near the upsilon(5S) resonance. Phys Rev Lett (2008) 1.02
Some in vivo and in vitro antitumour effects of the deoxyfluoro-D-glucopyranoses. Eur J Cancer (1973) 1.00
Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res (1989) 1.00
Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage. J Med Chem (1983) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Radioautographic studies of inulin, sulfate and chloride in rat and guinea pig thyroid glands. Endocrinology (1965) 0.99
Identification and endodontic management of three-canalled maxillary premolars. J Endod (1989) 0.98
A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem Pharmacol (1988) 0.97
Inhibition of protein prenylation by metabolites of limonene. Biochem Pharmacol (1999) 0.97
Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. Cancer Treat Rep (1986) 0.97
Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice. Br J Haematol (1998) 0.94
Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2). Biochem Pharmacol (1992) 0.94
Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer. Breast Cancer Res Treat (1993) 0.93
Attachment of fluorescent metal chelates to macromolecules using "bifunctional" chelating agents. Biochem Biophys Res Commun (1977) 0.93
Synthesis of 2-alkoxy-substituted thiophenes, 1,3-thiazoles, and related S-heterocycles via Lawesson's reagent-mediated cyclization under microwave irradiation: applications for liquid crystal synthesis. J Org Chem (2001) 0.93
Nicotine and cotinine effects on 3 alpha hydroxysteroid dehydrogenase in canine prostate. Life Sci (1988) 0.92
Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid. J Med Chem (1990) 0.92
The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth. Cancer Chemother Pharmacol (1994) 0.92
Myocardial uptake (rabbit) of six 99mTc-tagged pharmaceuticals and 85Sr after vasopressin-induced necrosis. J Nucl Med (1977) 0.92
Fluorinated carbohydrates: XII. 4-Deoxy-4-fluoro-D-glucose: an improved synthesis and the glycosyl fluoride derivatives. Carbohydr Res (1971) 0.91
Inhibition of 17 alpha-hydroxylase/C17-C20 lyase by bifluranol and its analogues. J Steroid Biochem (1989) 0.90
The quantitation of cyclophosphamide in human blood and urine by mass spectrometry-stable isotope dilution. Clin Chim Acta (1975) 0.90
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. J Med Chem (1990) 0.90
Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metabolite. Biomed Mass Spectrom (1983) 0.89
Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs. J Biol Chem (1990) 0.89
Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide. Anticancer Drug Des (1988) 0.89
Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Eur J Cancer (1978) 0.89
Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Carcinogenesis (1994) 0.88
Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis. J Med Chem (1990) 0.88
Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence. FEBS Lett (1995) 0.87
Polyploid nuclei in human artery wall smooth muscle cells. Proc Natl Acad Sci U S A (1983) 0.87
Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer. Cancer Res (1991) 0.87
Radium-induced eye melanomas in dogs. Radiat Res (1972) 0.87
Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans. Cancer Res (1979) 0.87
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
An old traditional herbal remedy for neonatal jaundice with a newly identified risk. J Paediatr Child Health (1993) 0.86
Polymorphically acetylated aminoglutethimide in humans. Br J Cancer (1982) 0.86
Clinical evaluation of ceftibuten in gonorrhea. A pilot study in Hong Kong. Sex Transm Dis (1998) 0.85
Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients. Drug Metab Dispos (1994) 0.85
Large cell carcinoma of lung with osteoclast-like giant cells. Histopathology (1998) 0.85
Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent. J Med Chem (1989) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Dependency of chelation efficacy upon time after first DTPA injection. Radiat Res (1979) 0.84